RE:Copied from ceo board For those who still hope to be able to buy lower, I believe that you will be disappointed to have missed the train ... we have reached the bottom in my opinion and I believe that we will see an upward trend take shape and review days parabolic hikes this fall. Very happy will be those who will have bought at this ridiculously low price.
bohemian62 wrote: This poster(clips) on the SCRN ceo board . I believe he is bang on in his assessment of SCRN . Hope he/she won't mind me posting it on our board here .
@Clips I had been using 19000 Tests for June in my numbers, so I can certainly live with 18500. It's nice to see them keeping Investors updated more often(at least they are responding to Investor's complaints). So now we have what they claim to be the numbers; 24000 in April, 19000 in May, & 18500 in June. Since to the best of my knowledge, we aren't aware how much they are getting Per/Test right now, we do know at one point(with a completely different type of Test though), they were getting $100/Test. I believe it highly-unlikely they are still getting $100 for each Test still, but since we don't actually know, for discussion sake, I have been using the number of $60 per Test. So ignoring any other potential sources of Revenue, using that $60 number, administering 61.5k, would be roughly $3.69M in Revenues for the Qtr. I've said this many times with their other Revenue updates and I'll say it again, there are many Companies on the Venture & TSX, who would be 'tickled-pink' to be getting anywhere near $3.69M of Revenue for the entire year(let alone 3 months). As some may believe we are still getting closer to $100/Test, I can't help but mention that would be around $6.2M for 3 months, and that would be exceptional lol. Steady as she goes, GLTA.